We use cookies to ensure the website works properly and to improve your experience. By continuing to use the website, you agree to their use.
Для размещения заказа оставьте ваш номер телефона. Мы с вами свяжемся в ближайшее время
Rapid Bio is one of Russia’s leading rapid diagnostics developers
First in Russia to register and launch domestic production of COVID-19 rapid tests in 2020.
25+ diagnostic products launched
90+ products in development
25+ diagnostic products launched
90+ products in development
The company develops rapid tests, laboratory diagnostics, microfluidic devices and NGS-based solutions.
Development of rapid tests for bedside diagnostics
Areas of Work
Development of test systems for laboratory diagnostics
Conducting clinical trials
Scientific and educational activities
German Khunteev
Science Director
The work of the R&D team is based on a scientific approach to developing the best solutions for the in vitro diagnostics market in strict compliance with Russian and international standards.
We are actively working on many projects to introduce new technological approaches into everyday medical practice.
We are confident that the Russian scientific and practical school is capable of creating and implementing products that set the standard on the global market.
We are confident that the Russian scientific and practical school is capable of creating and implementing products that set the standard on the global market.
INTERNATIONAL PRESENCE
Rapid Bio is strengthening its international presence across Europe, Asia and Africa. The company has registered diagnostic products in Europe, Thailand and Myanmar, is currently undergoing registration in South Africa, and is developing HIV and Malaria diagnostic solutions for the markets of Tanzania and South Africa.
Video About Us
From a small team of bioengineers to recognized industry experts — watch the video about how Rapid Bio develops and manufactures world-class test systems.
